Kainate-elicited seizures induce mRNA encoding a CaMK-related peptide: a putative modulator of kinase activity in rat hippocampus.

Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands.
Journal of Neurobiology (Impact Factor: 3.05). 05/1999; 39(1):41-50. DOI: 10.1002/(SICI)1097-4695(199904)39:13.0.CO;2-X
Source: PubMed

ABSTRACT By means of differential display techniques, we have previously identified an mRNA transcript whose expression is highly induced in the rat hippocampus by kainate-elicited seizures. Here, we report the cloning of a corresponding cDNA encoding a 55-amino-acid, serine-rich peptide which contains four predicted phosphorylation sites. The peptide was designated CaMK-related peptide (CARP) as it shares significant amino acid sequence identity with part of a novel putative calcium/calmodulin-dependent kinase (CaMK-VI) that was also cloned in this study. It appears that CARP and CaMK-VI are derived from the same gene through differential splicing. Intriguingly, CARP also exhibits 64% amino acid sequence identity with the C-terminal part of human doublecortin, encoded by a recently identified gene which is mutated in patients with X-linked lissencephaly and the double-cortex syndrome. In addition, the structure of CARP resembles the autoinhibitory, serine-rich N-terminal domain of CaMK-IV, suggesting a possible modulatory role of CARP with respect to CaMK activity. Northern blot analysis and in situ hybridization experiments showed that CARP mRNA is specifically induced by kainate-elicited seizures in the dentate gyrus and in the pyramidal layers CA1 and CA2, but not in CA3. In contrast, kainate-induced seizures did not change the level of expression of the CaMK-VI gene. We propose that CARP induction leads to the modulation of kinase activity in specific subregions of the rat hippocampus, providing a negative feedback mechanism for seizure-induced kinases.

  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Behavioral hyperresponsiveness entails major changes in neuronal plasticity, such as augmented striatal dopaminergic neurotransmission and changes in neuronal morphology. These two processes may be related via mechanisms involving Ca2+/calmodulin-dependent protein kinases (CaMK). Dopaminergic regulation of a newly characterized CaMK-like gene, i.e., doublecortin-like kinase (DCLK), has been reported. However, it is not known if and how CaMK-like splice variants of the gene are responsive in behavioral hyperresponsiveness induced by enhanced dopaminergic neurotransmission. We, therefore, measured with quantitative in situ hybridization levels of mRNA encoding the CaMK domain-containing gene product, called DCLK or a CaMK domain-lacking variant called CaMK-related peptide (CARP) in the rat striatum. We have applied three forms of behavioral hyperresponsiveness, viz. administration of selective dopamine agonists to animals with a unilaterally dopamine-depleted striatum and psychomotor sensitization to amphetamine or morphine. DCLK mRNA only showed changes after dopamine depletion, but not after subsequent treatment with dopamine agonists during expression of amphetamine or morphine sensitization. In contrast, CARP mRNA was dramatically increased in the dopamine-depleted striatum after administration of a dopamine D1 agonist. Furthermore, CARP was upregulated and downregulated during expression of amphetamine and morphine sensitization, respectively. CARP is suggested to play a role in morphological plasticity. We, therefore, propose that the observed changes are involved in dopamine-induced changes in striatal neuronal circuitry. A hypothetical model of action of CARP is presented.
    12/2008: pages 493-510;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Doublecortin-like (DCL) is a microtubule-binding protein crucial for neuroblastoma (NB) cell proliferation. We have investigated whether the anti-proliferative effect of DCL knockdown is linked to reduced mitochondrial activity. We found a delay in tumor development after DCL knockdown in vivo in doxycycline-inducible NB tumor xenografts. To understand the mechanisms underlying this tumor growth retardation we performed a series of in vitro experiments in NB cell lines. DCL colocalizes with mitochondria, interacts with the mitochondrial outer membrane protein OMP25/ SYNJ2BP and DCL knockdown results in decreased expression of genes involved in oxidative phosphorylation. Moreover, DCL knockdown decreases cytochrome c oxidase activity and ATP synthesis. We identified the C-terminal Serine/Proline-rich domain and the second microtubule-binding area as crucial DCL domains for the regulation of cytochrome c oxidase activity and ATP synthesis. Furthermore, DCL knockdown causes a significant reduction in the proliferation rate of NB cells under an energetic challenge induced by low glucose availability. Together with our previous studies, our results corroborate DCL as a key player in NB tumor growth in which DCL controls not only mitotic spindle formation and the stabilization of the microtubule cytoskeleton, but also regulates mitochondrial activity and energy availability, which makes DCL a promising molecular target for NB therapy.
    PLoS ONE 09/2013; 8(9):e75752. · 3.53 Impact Factor

Full-text (2 Sources)

Available from
Aug 20, 2014